🇺🇸 FDA
Patent

US 11795434

Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereof

granted A61KA61K35/12A61K35/28

Quick answer

US patent 11795434 (Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereof) held by L'Institut de Cardiologie de Montréal expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
L'Institut de Cardiologie de Montréal
Grant date
Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K35/12, A61K35/28, A61K35/34, A61P